22NW, LP Q2 2025 Filing

Filed August 14, 2025

Portfolio Value

$158.8B

Holdings

21

Report Date

Q2 2025

Filing Type

13F-HR

All Holdings (21 positions)

#StockSharesValue% PortfolioType
1
FSTRFOSTER L B CO
1,313,121$28.7B18.08%
2
LDELIFECORE BIOMEDICAL INC
264,180$22.6B14.25%
3
ANEBANEBULO PHARMACEUTICALS INC
15,467,300$22.3B14.03%
4
SRISTONERIDGE INC
1,943,508$13.7B8.62%
5
DHXDHI GROUP INC
3,299,937$9.8B6.17%
6
RGNXREGENXBIO INC
923,679$7.6B4.78%
7
MLYSMINERALYS THERAPEUTICS INC
560,042$7.6B4.77%
8
CULPCULP INC
1,859,061$7.3B4.60%
9
PFXPHENIXFIN CORP
117,885$6.0B3.76%
10
UFIUNIFI INC
981,535$5.1B3.23%
11
MGTXMEIRAGTX HLDGS PLC
586,519$3.8B2.41%
12
NKTRNEKTAR THERAPEUTICS
146,115$3.8B2.38%
13
CMTCORE MOLDING TECHNOLOGIES IN
191,222$3.2B2.00%
14
TISITEAM INC
171,090$3.1B1.96%
15
ARVNARVINAS INC
413,533$3.0B1.92%
16
FARMFARMER BROS CO
1,955,526$2.7B1.69%
17
MECMAYVILLE ENGR CO INC
155,450$2.5B1.56%
18
CMPSCOMPASS PATHWAYS PLC
882,844$2.5B1.56%
19
ELDNELEDON PHARMACEUTICALS INC
636,364$1.7B1.09%
20
E2OSTRATA SKIN SCIENCES INC
536,995$1.2B0.78%
21
PMDIPSYCHEMEDICS CORPORATION CMN
276,034$618.3M0.39%